Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK050693-01
Application #
2151742
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1996-03-15
Project End
2000-02-29
Budget Start
1996-03-15
Budget End
1997-02-28
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Pao, Lily I; Lam, Kong-Peng; Henderson, Joel M et al. (2007) B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27:35-48
Masiello, David; Mohi, M Golam; McKnight, Nicole C et al. (2007) Combining an mTOR antagonist and receptor tyrosine kinase inhibitors for the treatment of prostate cancer. Cancer Biol Ther 6:195-201
Pao, Lily I; Badour, Karen; Siminovitch, Katherine A et al. (2007) Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu Rev Immunol 25:473-523
Bentires-Alj, Mohamed; Gil, Susana G; Chan, Richard et al. (2006) A role for the scaffolding adapter GAB2 in breast cancer. Nat Med 12:114-21
Nagaishi, Takashi; Pao, Lily; Lin, Sue-Hwa et al. (2006) SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. Immunity 25:769-81
Yu, Min; Luo, Jincai; Yang, Wentian et al. (2006) The scaffolding adapter Gab2, via Shp-2, regulates kit-evoked mast cell proliferation by activating the Rac/JNK pathway. J Biol Chem 281:28615-26
Du, Zhimei; Shen, Yuhong; Yang, Wentian et al. (2005) Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc Natl Acad Sci U S A 102:10267-72
Togni, M; Swanson, K D; Reimann, S et al. (2005) Regulation of in vitro and in vivo immune functions by the cytosolic adaptor protein SKAP-HOM. Mol Cell Biol 25:8052-63
Rusanescu, Gabriel; Yang, Wentian; Bai, Ailin et al. (2005) Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicity. EMBO J 24:305-14
Mohi, M Golam; Williams, Ifor R; Dearolf, Charles R et al. (2005) Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7:179-91

Showing the most recent 10 out of 23 publications